Featured
Read our handpicked blogs, curated for you.
|
For Indian pharma, HCP engagement is no longer about reach; it’s about relevance and measurable impact. Boards want to…
|
Pharma marketing in India is at a turning point. Budgets have expanded, channels have multiplied, and compliance…
|
If you’re serious about HCP Engagement Tier 2 Cities, stop chasing metro playbooks. Tier 2 doctors don’t sit in front…
Recent releases
|
You vs. Your Competitor: Where Pharma CMOs Are Still Stuck
Pharma marketing in 2025 is no longer about how many reps you’ve got on the ground or how much money you're throwing at doctor conferences. It’s about how tight your systems are, how fast your…
|
What to Look for in a Doctor Engagement Platform in India (2025 Edition)
Let’s stop pretending the problem is content. Pharma marketers have no shortage of medical visuals, MOA videos, or emailers. The issue isn’t supply. It’s connection.Most pharma brands in India still…
|
What Doctors Want: The Unfiltered Truth from 500 HCPs Across India
Ask any pharma CMO in India what keeps them up at night, and you’ll likely get the same answer: doctors aren’t engaging like they used to. Field reps are getting fewer appointments. Email open rates…
|
MarTech for Pharmaceutical: How to Build a Pharma MarCom System That Moves at Speed
Pharma marketing isn’t slow because people are lazy. It’s slow because the system is broken. You’ve got a brand team ready with a campaign idea. The digital team is prepping creative assets. But…
